Xueying Wu

518 total citations
35 papers, 199 citations indexed

About

Xueying Wu is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Xueying Wu has authored 35 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 7 papers in Immunology and 6 papers in Surgery. Recurrent topics in Xueying Wu's work include Cancer Immunotherapy and Biomarkers (8 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Xueying Wu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), MicroRNA in disease regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Xueying Wu collaborates with scholars based in China, United States and Macao. Xueying Wu's co-authors include Henghui Zhang, Ying Hu, Beibei Mao, Lijia Wu, Huan Chen, Ying Yang, Yue Fan, Hao Yu, Junyan Han and Lan Zheng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Xueying Wu

31 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xueying Wu China 8 77 61 53 37 32 35 199
Rintaro Ohe Japan 10 74 1.0× 81 1.3× 52 1.0× 34 0.9× 25 0.8× 42 250
Anna Gurevich‐Shapiro Israel 6 117 1.5× 52 0.9× 115 2.2× 23 0.6× 12 0.4× 11 226
Anne Blank Germany 7 66 0.9× 59 1.0× 116 2.2× 16 0.4× 36 1.1× 12 276
Brian Hogan United Kingdom 8 100 1.3× 90 1.5× 41 0.8× 43 1.2× 76 2.4× 17 334
Gordana Petrushevska North Macedonia 8 85 1.1× 67 1.1× 21 0.4× 33 0.9× 27 0.8× 42 251
Shuai Zhu China 10 55 0.7× 83 1.4× 23 0.4× 84 2.3× 67 2.1× 21 245
Ákos Gasparics Hungary 8 74 1.0× 148 2.4× 23 0.4× 88 2.4× 31 1.0× 17 295
Giulia Pomati Italy 12 148 1.9× 51 0.8× 59 1.1× 63 1.7× 105 3.3× 27 392
Yanwen Wang China 10 140 1.8× 59 1.0× 26 0.5× 68 1.8× 63 2.0× 25 280

Countries citing papers authored by Xueying Wu

Since Specialization
Citations

This map shows the geographic impact of Xueying Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xueying Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xueying Wu more than expected).

Fields of papers citing papers by Xueying Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xueying Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xueying Wu. The network helps show where Xueying Wu may publish in the future.

Co-authorship network of co-authors of Xueying Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Xueying Wu. A scholar is included among the top collaborators of Xueying Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xueying Wu. Xueying Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yan, Yanyan, Xueying Wu, Yucheng Lu, et al.. (2025). Low miR-224–5p in exosomes confers colorectal cancer 5-FU resistance by upregulating S100A4. Drug Resistance Updates. 79. 101211–101211. 5 indexed citations
2.
3.
Xie, Yong, Yuhan Yang, Zhijun Chen, et al.. (2025). Na3V2(PO4)2F3/LiNi0.8Co0.1Mn0.1O2 composite as cathode for practical Li–Na hybrid ion batteries. Journal of Power Sources. 639. 236659–236659. 1 indexed citations
4.
Wu, Xueying, Xi Jiao, Ying Hu, et al.. (2024). Prognostic and predictive value of angiogenesis-associated serum proteins for immunotherapy in esophageal cancer. Journal for ImmunoTherapy of Cancer. 12(2). e006616–e006616. 15 indexed citations
5.
Yang, Guobin, et al.. (2024). Synergistic inhibition effect of thioureido imidazoline and cationic surfactants with different alkyl chain lengths on X80 carbon steel in CO2-saturated NaCl solutions. International Journal of Electrochemical Science. 19(12). 100869–100869. 1 indexed citations
6.
Jin, Jingjing, et al.. (2024). Circulating miR-129-3p in combination with clinical factors predicts vascular calcification in hemodialysis patients. Clinical Kidney Journal. 17(3). sfae038–sfae038. 2 indexed citations
7.
Li, Lan, Xueying Wu, Ziqi Lin, et al.. (2024). Coagulopathy and acute pancreatitis: pathophysiology and clinical treatment. Frontiers in Immunology. 15. 1477160–1477160. 2 indexed citations
8.
Hu, Ying, Huaibo Sun, Wei Shi, et al.. (2024). Immunogram defines four cancer-immunity cycle phenotypes with distinct clonal selection patterns across solid tumors. Journal of Translational Medicine. 22(1). 69–69. 1 indexed citations
9.
Wu, Xueying, Chenyang Zhang, & Henghui Zhang. (2022). Immune Effective Score as a Predictor of Response to Neoadjuvant Trastuzumab Therapy and a Prognostic Indicator for HER2-Positive Breast Cancer. Current Oncology. 29(1). 283–293. 1 indexed citations
10.
Zhou, Xiaohai, Chenyang Zhang, Xueying Wu, et al.. (2022). Dusp6 deficiency attenuates neutrophil-mediated cardiac damage in the acute inflammatory phase of myocardial infarction. Nature Communications. 13(1). 6672–6672. 23 indexed citations
11.
Xu, Fei, Haiyan Xu, Zhiyi Wan, et al.. (2022). A Linear Discriminant Analysis Model Based on the Changes of 7 Proteins in Plasma Predicts Response to Anlotinib Therapy in Advanced Non-Small Cell Lung Cancer Patients. Frontiers in Oncology. 11. 756902–756902. 3 indexed citations
12.
Liu, Xuefei, Yanping Xu, Xueying Wu, et al.. (2022). Soluble Immune-Related Proteins as New Candidate Serum Biomarkers for the Diagnosis and Progression of Lymphangioleiomyomatosis. Frontiers in Immunology. 13. 844914–844914. 3 indexed citations
13.
Wu, Xueying, Xian Zhang, Qing Du, et al.. (2021). Cytoplasmic CD79a is a promising biomarker for B lymphoblastic leukemia follow up post CD19 CAR-T therapy. Leukemia & lymphoma. 63(2). 426–434. 13 indexed citations
14.
Lv, Fang, Xueying Wu, Jin Sook Song, et al.. (2021). Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD). Biomarker Research. 9(1). 41–41. 1 indexed citations
15.
Zhang, Qiqi, et al.. (2021). Gene coexpression network approach to develop an immune prognostic model for pancreatic adenocarcinoma. World Journal of Surgical Oncology. 19(1). 112–112. 5 indexed citations
16.
Wu, Xueying, Beibei Mao, & Henghui Zhang. (2020). The mutation of homologous recombination repair genetics is a potential biomarker for immunotherapy in microsatellite stable colon cancer.. Journal of Clinical Oncology. 38(15_suppl). 4076–4076. 3 indexed citations
17.
Liu, Shuqiang, et al.. (2020). Analysis of the Expression of the TRBC1 in T lymphocyte tumors. Indian Journal of Hematology and Blood Transfusion. 37(2). 271–279. 2 indexed citations
18.
19.
20.
Han, Junyan, Xing Hao, Chunjing Jiang, et al.. (2016). Immature monocytes contribute to cardiopulmonary bypass-induced acute lung injury by generating inflammatory descendants. Thorax. 72(3). 245–255. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rintaro Ohe Breakdown of academic impact, for papers by Anna Gurevich‐Shapiro Breakdown of academic impact, for papers by Anne Blank Breakdown of academic impact, for papers by Brian Hogan Breakdown of academic impact, for papers by Gordana Petrushevska Breakdown of academic impact, for papers by Shuai Zhu Breakdown of academic impact, for papers by Ákos Gasparics Breakdown of academic impact, for papers by Giulia Pomati Breakdown of academic impact, for papers by Yanwen Wang
Rankless by CCL
2026